Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04150523 · ClinicalTrials.gov registry record

Perspectives on Prophylactic Antibiotic Use in Dermatologic Surgery

A clinical trial, sponsored by University of Pennsylvania.

Completed
Registry status
338
Enrollment target

NCT04150523: Completed study, sponsored by University of Pennsylvania.

NCT04150523 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 338 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04150523 has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
338 participants
Enrollment target

Study Summary

This is a prospective, multi-center observational survey study to uncover how antibiotic differences can influence utilization decisions. The purpose is to assess the trade-offs between drug side effects and infection prevention that patients are willing to make when taking prophylactic antibiotics. Misuse of antibiotics or non-adherence to prescribed regimens is a public health issue that may be due to a variety of reasons including unclear instructions, symptom improvement and adverse events Subjects will be healthcare providers (physician or nurse) and individuals 18+ years of age in the dermatologic surgery waiting area (including patients and accompanying individuals). Participants will complete a conjoint.ly survey and choose between treatment (antibiotic vs no antibiotic) scenarios.

Primary Outcome

Determine the trade-offs between surgical site infection prophylaxis and antibiotic-associated adverse effects that patients, healthcare providers and caregivers are willing to make

Interventions

  • OTHER Survey

Trial Details

FieldValue
Enrollment Target 338 participants
Start Date 2019-10-15
Est. Completion 2021-08-25
University of Pennsylvania

1,423 total trials

What the finished NCT04150523 record still lists

NCT04150523 is an observational study that tracks outcomes without assigning an intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.

NCT04150523 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04150523 about?

NCT04150523 is a clinical study titled "Perspectives on Prophylactic Antibiotic Use in Dermatologic Surgery". This is a prospective, multi-center observational survey study to uncover how antibiotic differences can influence utilization decisions. The purpose is to assess the trade-offs between drug side effects and infection prevention that patients are willing to make when taking prophylactic antibiotics....

What is the current status of trial NCT04150523?

This trial is currently completed. The enrollment target is 338 participants. The study started on 2019-10-15. Estimated completion is 2021-08-25.

What interventions are being tested in trial NCT04150523?

The interventions under investigation include: Survey (OTHER).

Who is sponsoring clinical trial NCT04150523?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03253263 · 338 participants · Phase 2

    A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

  • NCT05658731 · 338 participants · NA

    Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients

  • NCT06022939 · 338 participants · Phase 3

    Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

  • NCT04176172 · 340 participants · Phase 3

    Optimizing Tobacco Use Treatment for PLWHA

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04150523, the US trial registry maintained by the National Library of Medicine. NCT04150523 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.